Market success requires the right idea, smart positioning, and guaranteed marketability.
The product category — medicinal products, medical devices, or food supplements — determines the regulatory and time-related requirements and the strategic positioning in the market.
Diapharm advises the pharmaceutical and life sciences industry, in particular manufacturers of food supplements, food for special medical purposes (FSMP), and specialty foods.
Food supplements, especially borderline products that are deliberately positioned at the interface between food, medical devices, and pharmaceuticals, can be attractive additions to a product portfolio.
Diapharm supports companies in identifying which food supplements would complement their existing portfolio of pharmaceuticals and medical devices in a meaningful way while keeping a holistic approach to medical care.
From Idea to a Compliant Food Supplement.
Borderline Issues
Diapharm is familiar with the legal requirements for food supplements, medicinal products, medical devices, and cosmetics, and can help you develop the right strategy for your business goals.
Learn more
Portfolio Strategy
Diapharm analyzes existing product portfolios and offers ideas for further development and expansion, so you can be sure everything is aligned just right.
Learn more
Verification of Marketability
Diapharm assesses whether your existing product is marketable and helps you bring a safe and attractive product to market.
Learn more
Product Labelling
Diapharm supports complete and correct labelling and helps you avoid complaints from regulatory authorities.
Learn more
Health Claims
Health claims are what set a product apart on the market. Diapharm knows the regulatory requirements and how to apply them correctly.
Learn more
Food supplements — positioned between foods, medical devices and medicinal products — offer various opportunities to expand your product portfolio. Diapharm identifies the right products for your portfolio.
Diapharm accompanies you from product development to successful market establishment.
Sustainable market success can only be achieved if the advantages and disadvantages of the respective product category are known and taken into account; if labeling and product promises (health claims) are well thought out; if the marketability of formulas and active substances has been ensured; and finally, if you have the courage to break new ground.
Diapharm knows the strategies needed for optimal market positioning, can evaluate product ideas, and can weigh the benefits and risks for the portfolio.
Should competition proceedings or regulatory complaints arise, Diapharm will support you with its regulatory expertise.
Novel Food Authorizations
Novel foods are all foods that were not used for human consumption in the EU to a significant degree before May 15, 1997. To protect the population, these foods are subject to the Novel Food Regulation (EU) 2015/2283 and require approval from the European Food Safety Authority (EFSA). There are no patents on novel food authorizations, but the right strategy makes it difficult for competitors to imitate. Diapharm conducts feasibility analyses on this, prepares the necessary novel food dossier, and assists with advice before you submit an application to the EFSA.
A role at Diapharm combines communication with clarity, reliability with empathy, and precision with pragmatism.
You think holistically, across disciplines, and in a results-oriented way? You’re good at analyzing, assessing and making decisions? You understand people — both clients and colleagues? You communicate with confidence — both in German and English?
Then you’ll find exactly the right role at Diapharm.